The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
Kevin Harrington | Oncologist in Sutton - Doctify
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Descifrando la complejidad clínica del cáncer de cabeza y cuello – Fundación ECO para la Excelencia y Calidad en la Oncología
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington (@kevhar6763) / Twitter
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Potential of immunotherapy in head and neck cancer | VJOncology
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
Potential of immunotherapy in head and neck cancer | VJOncology
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
RM Magazine - spring 2012 - The Royal Marsden
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
